COMMUNIQUES

  14/11/2007   STADA: Strong growth in 1-9/2007: Sales +25%, operating profit +41% ...
19/10/2007 STADA receives “positive opinion” for Epo-zeta from EMEA ...
28/09/2007 STADA: Health care reform destroys 230 jobs in German sales ...
17/09/2007 STADA sales companies complete discount contracts with AOK for 23 APIs ...
14/08/2007 STADA: Strong growth continues in H1/2007 – sales 27%, net income 38% ...

20/06/2007

STADA AGM 2007: Executive Board confirms forecast of 12th record year in a row ...

15/05/2007

STADA: Successful start in 2007 – Q1: sales 20%, EBIT 28%, net income 22% ...

29/03/2007

STADA Group results 2006 confirm eleventh record year – optimistic outlook ...

20/11/2006

STADA reorganizes Biosimilar project –Epo-zeta distribution rights to Hospira ...

14/11/2006

STADA: Growth after nine months of 2006: Sales 18%, adjusted net income 27%  ...

08/09/2006

STADA: After squeeze-out procedure STADA now holds 100% of Hemofarm shares  ...

22/08/2006

STADA: Sale of US business executed as per contract from July 13, 2006...

10/08/2006 STADA: Strong growth continues in H1/2006 – sales 18%, net income 32% ...

04/08/2006

STADA: Appointment of the Executive Board extended...

14/07/2006

STADA bids for Serbian Hemofarm – access to 59% contractually agreed ...

30/06/2006

STADA: Approval documents for Erythropoietin biosimilar submitted to EMEA ...

14/06/2006

STADA AGM: Executive Board confirms further growth course in sales and earnings ...

30/05/2006 STADA: Price Reduction in the German market ...

15/05/2006

STADA: Very successful Q1/2006 ...

30/03/2006

STADA: Final financial figures for 2005 confirm robust growth course...

10/01/2006

STADA : Annual sales over 1 billion Euros...

22/12/2005 STADA: Current changes in STADA’s Executive...

12/10/2005

STADA special effects reduce net income...

11/08/2005

STADA results confirm record course...

14/06/2005

STADA Boards Presents Prospect...
12/05/2005 STADA buys Chinese production base Press release...
11/04/2005 STADA acquires Portuguese Generics supplier...

30/03/2005

STADA: Record Result in 2004...

25/03/2005

EG envisage de délocaliser la production...

04/03/2005

9th Record Year in 2004 for STADA...

 

 

 

Whitepaper

Witboek over de generische geneesmiddelen


WhitepaperNL.doc

Eurogenerics - Heizel Esplanade b 22 - 1020 Brussel - T: 02 479 78 78